XML 103 R84.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Commitments and Contingencies (Details) - USD ($) $ in Thousands |  | 3 Months Ended |  |
--- | --- | --- | --- | ---
Jan. 03, 2022 | Jun. 30, 2023 | Nov. 07, 2022 | Feb. 02, 2022
Other Commitments [Line Items] |  |  |  |
Proceeds from litigation settlement |  | $ 1,000 |  |
Melinta Therapeutics, LLC and Targanta Therapeutics Corporation | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement |  |  |  |
Other Commitments [Line Items] |  |  |  |
Sales milestone payments, receivable |  |  | $ 1,000 |
Melinta Therapeutics, LLC and Targanta Therapeutics Corporation | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Within 30 Days Of First sNDA Filing |  |  |  |
Other Commitments [Line Items] |  |  |  |
Sales milestone payments, receivable |  |  |  | $ 500
Melinta Therapeutics, LLC and Targanta Therapeutics Corporation | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Following Approval Of First sNDA |  |  |  |
Other Commitments [Line Items] |  |  |  |
Sales milestone payments, receivable |  |  |  | $ 500
U.S. Product Asset Rights - Sancuso |  |  |  |
Other Commitments [Line Items] |  |  |  |
Tiered royalty payments, threshold | $ 3,500 |  |  |
Tiered royalty payments term (in years) | 10 years |  |  |
U.S. Product Asset Rights - Sancuso | Maximum |  |  |  |
Other Commitments [Line Items] |  |  |  |
Tiered royalty payments (percentage) | 10.00% |  |  |
U.S. Product Asset Rights - Sancuso | Minimum |  |  |  |
Other Commitments [Line Items] |  |  |  |
Tiered royalty payments (percentage) | 5.00% |  |  |

X
- Definition Collaborative Arrangement, Rights and Obligations, Sales Milestone Payments, Receivable + References No definition available. + Details
Name: | cpix_CollaborativeArrangementRightsAndObligationsSalesMilestonePaymentsReceivable
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Payments To Acquire Business, Tiered Royalty Payments, Percentage + References No definition available. + Details
Name: | cpix_PaymentsToAcquireBusinessTieredRoyaltyPaymentsPercentage
Namespace Prefix: | cpix_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payments To Acquire Business, Tiered Royalty Payments, Term + References No definition available. + Details
Name: | cpix_PaymentsToAcquireBusinessTieredRoyaltyPaymentsTerm
Namespace Prefix: | cpix_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payments To Acquire Business, Tiered Royalty Payments, Threshold + References No definition available. + Details
Name: | cpix_PaymentsToAcquireBusinessTieredRoyaltyPaymentsThreshold
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_OtherCommitmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash received for the settlement of litigation during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_ProceedsFromLegalSettlements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=cpix_MelintaTherapeuticsLLCAndTargantaTherapeuticsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cpix_CollaborativeArrangementMilestonePaymentThresholdAxis=cpix_Within30DaysOfFirstSNDAFilingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cpix_CollaborativeArrangementMilestonePaymentThresholdAxis=cpix_FollowingApprovalOfFirstSNDAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=cpix_U.S.ProductAssetRightsSancusoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |